| Utility: USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS Filling date: 26 Sep 2025 Issue date: 4 Aug 2022 | 19 Apr 2022 | 4 Aug 2022 |
| Utility: Gaboxadol for therapeutic treatment of 1p36 deletion syndrome Filling date: 26 Sep 2025 Issue date: 21 Jun 2022 | 18 Dec 2020 | 21 Jun 2022 |
| Utility: USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS Filling date: 26 Sep 2025 Issue date: 14 Apr 2022 | 21 Dec 2021 | 14 Apr 2022 |
| Utility: Use of gaboxadol in the treatment of diabetes and related conditions Filling date: 26 Sep 2025 Issue date: 5 Apr 2022 | 8 Oct 2020 | 5 Apr 2022 |
| Utility: Methods for treating aggression associated with Alzheimer's disease Filling date: 26 Sep 2025 Issue date: 22 Mar 2022 | 29 Jun 2018 | 22 Mar 2022 |
| Utility: PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TREATMENT Filling date: 26 Sep 2025 Issue date: 10 Feb 2022 | 21 Oct 2021 | 10 Feb 2022 |
| Utility: METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA Filling date: 26 Sep 2025 Issue date: 20 Jan 2022 | 30 Sep 2021 | 20 Jan 2022 |
| Utility: TREATMENT OF DEPRESSIVE DISORDERS Filling date: 26 Sep 2025 Issue date: 9 Dec 2021 | 18 Aug 2021 | 9 Dec 2021 |
| Utility: RECOMBINANT ADENO-ASSOCIATED VECTORS Filling date: 26 Sep 2025 Issue date: 2 Dec 2021 | 12 Aug 2021 | 2 Dec 2021 |
| Utility: Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome Filling date: 26 Sep 2025 Issue date: 28 Sep 2021 | 7 Jul 2020 | 28 Sep 2021 |
| Utility: METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER Filling date: 26 Sep 2025 Issue date: 16 Sep 2021 | 2 Jun 2021 | 16 Sep 2021 |
| Utility: Methods of treating developmental disorders with gaboxadol Filling date: 26 Sep 2025 Issue date: 24 Aug 2021 | 17 Dec 2018 | 24 Aug 2021 |
| Utility: Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering Filling date: 26 Sep 2025 Issue date: 17 Aug 2021 | 20 Aug 2020 | 17 Aug 2021 |
| Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS Filling date: 26 Sep 2025 Issue date: 15 Jul 2021 | 30 Mar 2021 | 15 Jul 2021 |
| Utility: GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME Filling date: 26 Sep 2025 Issue date: 24 Jun 2021 | 18 Dec 2020 | 24 Jun 2021 |
| Utility: USE OF GABOXADOL IN THE TREATMENT OF GASTROINTESTINAL TRACT DISORDERS AND ASTHMA Filling date: 26 Sep 2025 Issue date: 17 Jun 2021 | 22 Aug 2019 | 17 Jun 2021 |
| Utility: USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS Filling date: 26 Sep 2025 Issue date: 8 Apr 2021 | 16 Oct 2020 | 8 Apr 2021 |
| Utility: USE OF MIR101 OR MIR128 IN THE TREATMENT OF SEIZURE DISORDERS Filling date: 26 Sep 2025 Issue date: 1 Apr 2021 | 17 Nov 2020 | 1 Apr 2021 |
| Utility: Methods of treating developmental disorders and/or seizure disorders with etifoxine Filling date: 26 Sep 2025 Issue date: 23 Feb 2021 | 13 Aug 2019 | 23 Feb 2021 |
| Utility: USE OF GABOXADOL IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS Filling date: 26 Sep 2025 Issue date: 4 Feb 2021 | 8 Oct 2020 | 4 Feb 2021 |
| Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL Filling date: 26 Sep 2025 Issue date: 4 Feb 2021 | 25 Jun 2020 | 4 Feb 2021 |
| Utility: PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TREATMENT Filling date: 26 Sep 2025 Issue date: 21 Jan 2021 | 15 Jul 2020 | 21 Jan 2021 |
| Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS Filling date: 26 Sep 2025 Issue date: 7 Jan 2021 | 17 Sep 2020 | 7 Jan 2021 |
| Utility: Use of MIR101 or MIR128 in the treatment of seizure disorders Filling date: 26 Sep 2025 Issue date: 22 Dec 2020 | 6 Dec 2018 | 22 Dec 2020 |
| Utility: USE OF GABOXADOL FOR THE TREATMENT OF TOURETTE SYNDROME, TICS AND STUTTERING Filling date: 26 Sep 2025 Issue date: 3 Dec 2020 | 20 Aug 2020 | 3 Dec 2020 |
| Utility: Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders Filling date: 26 Sep 2025 Issue date: 27 Oct 2020 | 7 Jun 2019 | 27 Oct 2020 |
| Utility: Use of Gaboxadol in the treatment of diabetes and related conditions Filling date: 26 Sep 2025 Issue date: 27 Oct 2020 | 2 Aug 2018 | 27 Oct 2020 |
| Utility: USE OF MIR-92A OR MIR-145 IN THE TREATMENT OF ANGELMAN SYNDROME Filling date: 26 Sep 2025 Issue date: 22 Oct 2020 | 7 Jul 2020 | 22 Oct 2020 |
| Utility: Methods and compositions for treatment of epileptic disorders Filling date: 26 Sep 2025 Issue date: 13 Oct 2020 | 13 Feb 2020 | 13 Oct 2020 |
| Utility: Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering Filling date: 26 Sep 2025 Issue date: 8 Sep 2020 | 20 Sep 2019 | 8 Sep 2020 |
| Utility: Methods of treating developmental encephalopathies Filling date: 26 Sep 2025 Issue date: 8 Sep 2020 | 12 Apr 2018 | 8 Sep 2020 |
| Utility: Methods of treating developmental syndromes with PDE10A inhibitors Filling date: 26 Sep 2025 Issue date: 11 Aug 2020 | 15 Feb 2019 | 11 Aug 2020 |
| Utility: USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION Filling date: 26 Sep 2025 Issue date: 6 Aug 2020 | 17 Apr 2020 | 6 Aug 2020 |
| Utility: USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY Filling date: 26 Sep 2025 Issue date: 16 Jul 2020 | 25 Mar 2020 | 16 Jul 2020 |
| Utility: Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome Filling date: 26 Sep 2025 Issue date: 7 Jul 2020 | 14 Jun 2019 | 7 Jul 2020 |
| Utility: USE OF GABOXADOL FOR THE TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER Filling date: 26 Sep 2025 Issue date: 18 Jun 2020 | 17 Dec 2019 | 18 Jun 2020 |
| Utility: TREATMENT OF DEPRESSIVE DISORDERS Filling date: 26 Sep 2025 Issue date: 11 Jun 2020 | 19 Feb 2020 | 11 Jun 2020 |
| Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS Filling date: 26 Sep 2025 Issue date: 11 Jun 2020 | 13 Feb 2020 | 11 Jun 2020 |
| Utility: Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction Filling date: 26 Sep 2025 Issue date: 19 May 2020 | 8 Feb 2019 | 19 May 2020 |
| Utility: USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS Filling date: 26 Sep 2025 Issue date: 7 May 2020 | 5 Nov 2019 | 7 May 2020 |
| Utility: Methods and compositions for treatment of epileptic disorders Filling date: 26 Sep 2025 Issue date: 31 Mar 2020 | 20 Jun 2019 | 31 Mar 2020 |
| Utility: USE OF GABOXADOL FOR THE TREATMENT OF TOURETTE SYNDROME, TICS AND STUTTERING Filling date: 26 Sep 2025 Issue date: 26 Mar 2020 | 20 Sep 2019 | 26 Mar 2020 |
| Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH ETIFOXINE Filling date: 26 Sep 2025 Issue date: 2 Jan 2020 | 13 Aug 2019 | 2 Jan 2020 |
| Utility: METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME Filling date: 26 Sep 2025 Issue date: 2 Jan 2020 | 8 Feb 2018 | 2 Jan 2020 |
| Utility: USE OF MIR-92A OR MIR-145 IN THE TREATMENT OF ANGELMAN SYNDROME Filling date: 26 Sep 2025 Issue date: 19 Dec 2019 | 14 Jun 2019 | 19 Dec 2019 |
| Utility: USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS Filling date: 26 Sep 2025 Issue date: 12 Dec 2019 | 7 Jun 2019 | 12 Dec 2019 |
| Utility: Methods of treating behavioral syndromes using pipradrol Filling date: 26 Sep 2025 Issue date: 3 Dec 2019 | 8 Nov 2018 | 3 Dec 2019 |
| Utility: METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER Filling date: 26 Sep 2025 Issue date: 21 Nov 2019 | 17 May 2019 | 21 Nov 2019 |
| Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS AND/OR SEIZURE DISORDERS WITH FLUPIRTINE Filling date: 26 Sep 2025 Issue date: 31 Oct 2019 | 20 Jun 2019 | 31 Oct 2019 |
| Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL Filling date: 26 Sep 2025 Issue date: 24 Oct 2019 | 25 Jun 2019 | 24 Oct 2019 |
